首页  >  学科前沿 {{articleInfo.dynamicName}}  > 治疗药物监测杂志文章信息(2023年第45卷第5期)

治疗药物监测杂志文章信息(2023年第45卷第5期)

{{releTime.slice(0,10)}}     来源:药物治疗网     编辑:艾玉娇     阅读量:11788

August 2023 - Volume 45 - Issue 4(2023年10月第45卷第5期)
https://journals.lww.com/drug-monitoring/pages/currenttoc.aspx

      Grand Rounds(大查房)
      1. 接受治疗剂量预防术后癫痫发作的苯妥英中毒:一项病例研究
      (Phenytoin Intoxication in a Patient Receiving a Therapeutic Dose for Postoperative Seizure Prophylaxis: A Case Study)
      作者:Prasertsup, Warisa; Jariya Phuditshinnapatra* (Department of Preventive and Social Medicine, Faculty of Medicine, Siriraj Hospital, Mahidol University, Siriraj Poison Control Center, Thailand)  

      2. 一例严重多药中毒中的延迟锂再中毒:病例研究
      (Delayed Lithium Reintoxication in a Case of Severe Multidrug Intoxication: A Case Study)
      作者:Liang, Jiayi* (Department of Hospital Pharmacy, Maasstad Hospital, the Netherlands)

      Review Article(综述文章)
      1. 治疗药物监测的挑战:优化炎症性肠病和其他免疫介导的炎症性疾病患者的生物治疗
      (Challenges in Therapeutic Drug Monitoring: Optimizing Biological Treatments in Patients With Inflammatory Bowel Disease and Other Immune-Mediated Inflammatory Diseases)
      作者:Papamichael, Konstantinos* (Department of Medicine, Division of Gastroenterology, Beth Israel Deaconess Medical Center, USA)

      Original Article(原创文章)
      1. 小儿肾移植受者吗替麦考酚酯剂量调整
      (Mycophenolate Mofetil Dose Adjustment in Pediatric Kidney Transplant Recipients)
      作者:Labriffe, Marc; Pierre Marquet* (Department of Pharmacology, Toxicology and Pharmacovigilance, France)

      2. 使用LC-MS/MS测定人血浆中的奥布替尼
      (Determination of Orelabrutinib in Human Plasma Using LC-MS/MS)
      作者:Zhao, Yang, Yong-Qing Wang* (Research Division of Clinical Pharmacology, First Affiliated Hospital of Nanjing Medical University, China; Research Division of Clinical Pharmacology, First Affiliated Hospital of Nanjing Medical University, China)

      3. 10种β-内酰胺类抗生素于不同储存条件下在人血浆中的稳定性
      (Stability of 10 Beta-Lactam Antibiotics in Human Plasma at Different Storage Conditions)
      作者:Bahmany, Soma* (Department of Hospital Pharmacy, Erasmus MC, The Netherlands )

      4. 基于PopPK模型模拟的危重患者妥布霉素优先给药方案:它们是否可以转换?
      (Tobramycin a Priori Dosing Regimens Based on PopPK Model Simulations in Critically Ill Patients: Are They Transferable?)
      作者:Duong, Alexandre* (Faculté de Pharmacie - Université de Montréal, Canada)

      5. 开发一种儿童美罗培南的定量方法——体积吸收微量采样与血浆采样
      (Developing a Method for Quantifying Meropenem in Children—Volumetric Adsorptive Microsampling Versus Plasma Sampling)
      作者:Ramadan, Ola, Georg Hempel* (Department of Pharmaceutical and Medical Chemistry, Clinical Pharmacy, University of Münster, Germany;  Westfälische Wilhelms-Universität Münster, Institut für Pharmazeutische und Medizinische Chemie, Klinische Pharmazie, Germany)

      6. 严重感染的成人患者使用万古霉素给药指南的计算机评估
      (In silico Evaluation of a Vancomycin Dosing Guideline Among Adults with Serious Infections)
      作者:Paul Williams* (Pharmacy Department, Sunshine Coast University Hospital, Australia) 

      7. 在马里和法国中心的血液透析患者中万古霉素的群体药代动力学和最佳负荷剂量的模拟
      (Population Pharmacokinetics of Vancomycin in Patients Receiving Hemodialysis in a Malian and a French Center and Simulation of the Optimal Loading Dose)
      作者:Coulibaly, Balla, Sylvain Goutelle* (Univ Lyon, Université Claude Bernard Lyon 1, France; Hospices Civils de Lyon, Groupement Hospitalier Nord, Hôpital Pierre Garraud, Service de Pharmacie, France)

      8. 青少年和成人迟发性庞贝氏症患者α -葡糖苷酶个体暴露的群体药代动力学模型和测定:I期至III期临床试验的汇总数据分析
      (Population Pharmacokinetic Modeling and Determination of Individual Exposure to Avalglucosidase Alfa in Adolescent and Adult Patients With Late-Onset Pompe Disease: Analysis of Pooled Data From Phase I to III Clinical Trials)
      作者:Tuffal, Gilles, Tiraboschi Gilles* (Pharmacokinetics Dynamics and Metabolism, Translational Medicine and Early Development, Sanofi, France; Sanofi, France)

      9. 应用酶诱导模型分析癫痫患者吡仑帕奈与卡马西平之间药物相互作用的群体药代动力学
      (Population Pharmacokinetic Analysis of Drug–Drug Interactions Between Perampanel and Carbamazepine Using Enzyme Induction Model in Epileptic Patients)
      作者:Fujita, Yuito, Ichiro Ieiri* (Department of Clinical Pharmacokinetics, Graduate School of Pharmaceutical Science, Kyushu University, Japan; Department of Pharmacy, Kyushu University Hospital, Japan)

      10. 吡仑帕奈治疗难治性癫痫患儿的治疗药物监测:关注游离吡仑帕奈浓度的影响因素
      (Therapeutic Drug Monitoring of Perampanel in Children With Refractory Epilepsy: Focus on Influencing Factors on the Free-Perampanel Concentration)
      作者:Qu, Ru, Xuqin Chen* (Department of Neurology, Children's Hospital of Soochow University, China)

      11. 通过测量溃疡性结肠炎患者的粪便排泄来监测美沙拉嗪治疗药物的潜力
      (Potential of Mesalazine Therapeutic Drug Monitoring by Measuring Fecal Excretion in Patients With Ulcerative Colitis)
      作者:Maartje M. van de Meeberg* (University Medical Center Utrecht, Department of Gastroenterology and Hepatology, the Netherlands)

      12. 年龄、性别及合并用药对中国精神分裂症患者氨磺必利稳态血浆浓度的影响
      (Age, Sex, and Comedication Effects on the Steady-State Plasma Concentrations of Amisulpride in Chinese Patients with Schizophrenia)
      作者:Yang, Shuo,  Yi Wan* (Department of Pharmacy, Jianyang People's Hospital, China; Zigong Affiliated Hospital of Southwest Medical University, China)

      13. CYP2D6基因型对帕罗西汀血药浓度的影响
      (Impact of CYP2D6 Genotype on Paroxetine Serum Concentration)
      作者:Kristine Hole* (Center for Psychopharmacology, Diakonhjemmet Hospital, Norway)

      14. 普通吸食者吸食大麻后的可变δ-9-四氢大麻酚药代动力学和药效动力学
      (Variable Delta-9-Tetrahydrocannabinol Pharmacokinetics and Pharmacodynamics After Cannabis Smoking in Regular Users)
      作者:Liyanage, Marlon, Jeremiah D. Momper* (Skaggs School of Pharmacy and Pharmaceutical Sciences, University of California)

      Short Communication(短通信)
      1. 庆大霉素在透析患者中的应用:血液透析之前还是之后?
      (Gentamicin Administration in Dialysis Patients: Before or After Hemodialysis?)
      作者:Grit, Geeske F.; Daan J. Touw* (Department of Clinical Pharmacy and Pharmacology, University Medical Center Groningen, University of Groningen, the Netherlands)

      Letters to the Editor(给编辑的信)
      1. 对 “四十年来地高辛免疫测定的显著改进:新的测定法较少干扰影响” 的评论。以阿帕他胺干扰为例
      (Comment on “Significant Improvement in Digoxin Immunoassays Over Four Decades: Newer Assays Are Less Affected by Interferences.” The Case of Apalutamide Interference)
       作者:Maenhout, Yorich (Department of Laboratory Medicine, Ghent University Hospital, Belgium)

      2. 治疗药物监测在管理糖尿病足骨髓炎患者中克林霉素-利福平相互作用中的作用
      (Usefulness of Therapeutic Drug Monitoring to Manage Clindamycin–Rifampicin Interaction in a Patient with Diabetic Foot Osteomyelitis)
      作者:Magréault, Sophie (Department of Pharmacology, AP-HP, Jean Verdier Hospital, Sorbonne Paris Nord and Sorbonne Paris Cité University, France)

      3. 模型引导的精准给药不能排除治疗药物监测咨询
      (Therapeutic Drug Monitoring Consulting Cannot be Ruled out by Model-Informed Precision Dosing)
      作者:Launay, Manon (Service de Médecine Intensive Réanimation et Pôle de Biologie-Pathologie, France)

      4. 胎儿酒精综合征导致终止妊娠病例中同时测定乙醇的直接血液生物标志物
      (Simultaneous Determination of Direct Blood Biomarkers of Ethanol in a Fetal Alcohol Syndrome Case Leading to Pregnancy Termination)
      作者:Hakim, Florian (Toxicology Unit, Lille University Hospital, France)

      5. 环丙胺对映异构体血浆浓度可用于外周单胺氧化酶抑制的试验
      (Enantiomer Plasma Concentrations of Tranylcypromine as a Test for Peripheral Monoamine Oxidase Inhibition)
      作者:Sven Ulrich* (Aristo Pharma GmbH, Medical-Scientific Department, Germany)

网友评论